SUN-749 Impact of Treatment with Burosumab versus Conventional Therapy on Patient-Important Outcomes in Adult X-Linked Hypophosphatemia: A Retrospective and Prospective Cohort Study [PDF]
Dalal S. Ali +7 more
openalex +1 more source
Burosumab treatment for FGF23-related hypophosphatemia in a two-year-old girl with McCune-Albright syndrome. [PDF]
Clin Pediatr EndocrinolSaito T +7 more
europepmc +1 more source
Hypophosphatemia across the lifespan. [PDF]
JBMR PlusHerath M, Prince R, Munns CF, Kim A.
europepmc +1 more source
#2015 Burosumab therapy in adult patients with X-linked hypophosphatemia: a three-year follow-up study [PDF]
Silverio Rotondi +8 more
openalex +1 more source
X-linked hypophosphatemia and tumor-induced osteomalacia: a narrative review and expert opinion on the diagnostic and therapeutic challenges in the era of burosumab. [PDF]
Orphanet J Rare DisBrandi ML +6 more
europepmc +1 more source
Real-World Clinical and Healthcare Resource Burden Among Burosumab-Naïve Patients With Familial Hypophosphatemia [PDF]
Erik A. Imel +6 more
openalex +1 more source
X-Linked Hypophosphatemia in a Family Cohort: Clinical Variability, Genetic Confirmation and Modern Therapeutic Perspectives. [PDF]
J Clin MedPopa O +5 more
europepmc +1 more source
What is it like living with X-linked hypophosphatemia?: results from an Australian consumer survey. [PDF]
JBMR PlusSandy JL +9 more
europepmc +1 more source
SUN-736 Non-interventional Post-authorisation Safety Study Of Burosumab In The Treatment Of Adults With X-linked Hypophosphataemia: First Interim Analysis [PDF]
Gema Ariceta +20 more
openalex +1 more source
Decision letter for "Burosumab for the Treatment of Tumor-Induced Osteomalacia"
, 2020 openalex +1 more source